AA
CLB icon

AlphaMark Advisors’s Core Laboratories CLB Stock Holding History

AlphaMark Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$20K Sell
1,150
-30
-3% -$579 0.01% 352
2024
Q3 		$22K Sell
1,180
-15
-1% -$301 0.01% 422
2024
Q2 		$24K Sell
1,195
-355
-23% -$6.28K 0.01% 428
2024
Q1 		$26K Buy
+1,550
New +$24.4K 0.01% 418

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

AlphaMark Advisors's CLB Position: Q4 2024 in Review

AlphaMark Advisors reduced its Core Laboratories (CLB) stake by 2.5% in Q4 2024, selling an estimated $579 and leaving 1,150 shares worth $20K. The position accounts for 0.01% of the portfolio, ranked #352.

AlphaMark Advisors first reported a position in CLB in Q1 2024 and has held it in 4 quarters since. The position peaked at $26K in Q1 2024. 209 funds tracked by Wall St. Rank hold CLB as of Q4 2024.

  • AlphaMark Advisors held 1,150 shares of Core Laboratories worth $20K as of Q4 2024.
  • AlphaMark Advisors sold 30 Core Laboratories shares in Q4 2024, an estimated $579.
  • Core Laboratories made up 0.01% of AlphaMark Advisors's portfolio in Q4 2024, its #352 holding.
  • AlphaMark Advisors first reported a position in Core Laboratories in Q1 2024 and has held it in 4 quarters since.
  • AlphaMark Advisors's Core Laboratories position peaked at $26K in Q1 2024.
  • 209 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2024.

Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.